Moleculin Biotech
MBRX58
$0.95arrow_drop_up1.91%$0.01
High Growth
Penny Stock
MBRX58
$0.95
arrow_drop_up1.91%
There's no data available for key stats
There's no data available for ratios/profitability stats
| Fundamentals | |
|---|---|
| Gross Profit | - |
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | Feb 1, 2021 |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
MBRX-
US Healthcare Sector-
US Market-
check_circle
MBRX / Market
MBRX exceeded the US Market which returned 0.03% over the last twenty four hours.warning
MBRX / Healthcare Sector
MBRX lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.Moleculin Biotech (MBRX) Statistics
Keep an eye on Moleculin Biotech
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Moleculin Biotech (MBRX) stock's performance compared to its sector and the market over the past year?
Over the past year, Moleculin Biotech (MBRX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Moleculin Biotech has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Moleculin Biotech 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Moleculin Biotech (MBRX) stock?
The PE ratio for Moleculin Biotech (MBRX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Moleculin Biotech (MBRX) stock?
The Earnings Per Share (EPS) for Moleculin Biotech (MBRX), calculated on a diluted basis, is -$12.04. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Moleculin Biotech (MBRX) stock?
The operating margin for Moleculin Biotech (MBRX) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Moleculin Biotech (MBRX) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Moleculin Biotech (MBRX) is -$28.79M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Moleculin Biotech (MBRX) have?
Moleculin Biotech (MBRX) has a total debt of $506K. The net debt, which accounts for cash and cash equivalents against the total debt, is -$8.9M.